These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 31883707)
1. Targeting Plasmodium Plasmepsin V: Hitting Two Birds with One Stone. Brancucci NMB; Heussler VT; Grüring C Trends Parasitol; 2020 Feb; 36(2):85-87. PubMed ID: 31883707 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of Plasmepsin V Activity Blocks Plasmodium falciparum Gametocytogenesis and Transmission to Mosquitoes. Jennison C; Lucantoni L; O'Neill MT; McConville R; Erickson SM; Cowman AF; Sleebs BE; Avery VM; Boddey JA Cell Rep; 2019 Dec; 29(12):3796-3806.e4. PubMed ID: 31851913 [TBL] [Abstract][Full Text] [Related]
3. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes. Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367 [TBL] [Abstract][Full Text] [Related]
4. Assessment of Biological Role and Insight into Druggability of the Polino AJ; Nasamu AS; Niles JC; Goldberg DE ACS Infect Dis; 2020 Apr; 6(4):738-746. PubMed ID: 32069391 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Plasmepsin V activity demonstrates its essential role in protein export, PfEMP1 display, and survival of malaria parasites. Sleebs BE; Lopaticki S; Marapana DS; O'Neill MT; Rajasekaran P; Gazdik M; Günther S; Whitehead LW; Lowes KN; Barfod L; Hviid L; Shaw PJ; Hodder AN; Smith BJ; Cowman AF; Boddey JA PLoS Biol; 2014 Jul; 12(7):e1001897. PubMed ID: 24983235 [TBL] [Abstract][Full Text] [Related]
6. Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P Nguyen W; Hodder AN; de Lezongard RB; Czabotar PE; Jarman KE; O'Neill MT; Thompson JK; Jousset Sabroux H; Cowman AF; Boddey JA; Sleebs BE Eur J Med Chem; 2018 Jun; 154():182-198. PubMed ID: 29800827 [TBL] [Abstract][Full Text] [Related]
7. Targeting the Plasmodium falciparum plasmepsin V by ligand-based virtual screening. Meissner KA; Kronenberger T; Maltarollo VG; Trossini GHG; Wrenger C Chem Biol Drug Des; 2019 Mar; 93(3):300-312. PubMed ID: 30320974 [TBL] [Abstract][Full Text] [Related]
8. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region. Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224 [TBL] [Abstract][Full Text] [Related]
9. Transition state mimetics of the Plasmodium export element are potent inhibitors of Plasmepsin V from P. falciparum and P. vivax. Sleebs BE; Gazdik M; O'Neill MT; Rajasekaran P; Lopaticki S; Lackovic K; Lowes K; Smith BJ; Cowman AF; Boddey JA J Med Chem; 2014 Sep; 57(18):7644-62. PubMed ID: 25167370 [TBL] [Abstract][Full Text] [Related]
10. Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle. Favuzza P; de Lera Ruiz M; Thompson JK; Triglia T; Ngo A; Steel RWJ; Vavrek M; Christensen J; Healer J; Boyce C; Guo Z; Hu M; Khan T; Murgolo N; Zhao L; Penington JS; Reaksudsan K; Jarman K; Dietrich MH; Richardson L; Guo KY; Lopaticki S; Tham WH; Rottmann M; Papenfuss T; Robbins JA; Boddey JA; Sleebs BE; Sabroux HJ; McCauley JA; Olsen DB; Cowman AF Cell Host Microbe; 2020 Apr; 27(4):642-658.e12. PubMed ID: 32109369 [TBL] [Abstract][Full Text] [Related]
11. An aspartyl protease directs malaria effector proteins to the host cell. Boddey JA; Hodder AN; Günther S; Gilson PR; Patsiouras H; Kapp EA; Pearce JA; de Koning-Ward TF; Simpson RJ; Crabb BS; Cowman AF Nature; 2010 Feb; 463(7281):627-31. PubMed ID: 20130643 [TBL] [Abstract][Full Text] [Related]
12. Targeting the plasmepsin 4 orthologs of Plasmodium sp. with "double drug" inhibitors. Janka L; Clemente J; Vaiana N; Sparatore A; Romeo S; Dunn BM Protein Pept Lett; 2008; 15(9):868-73. PubMed ID: 18991760 [TBL] [Abstract][Full Text] [Related]
13. Malaria parasite plasmepsins: More than just plain old degradative pepsins. Nasamu AS; Polino AJ; Istvan ES; Goldberg DE J Biol Chem; 2020 Jun; 295(25):8425-8441. PubMed ID: 32366462 [TBL] [Abstract][Full Text] [Related]
14. Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II. Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B Bioorg Med Chem; 2003 Mar; 11(6):827-41. PubMed ID: 12614868 [TBL] [Abstract][Full Text] [Related]
15. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534 [TBL] [Abstract][Full Text] [Related]
19. New inhibitors of the malaria aspartyl proteases plasmepsin I and II. Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B Bioorg Med Chem; 2003 Aug; 11(16):3423-37. PubMed ID: 12878137 [TBL] [Abstract][Full Text] [Related]
20. The integration of genomic and structural information in the development of high affinity plasmepsin inhibitors. Nezami A; Freire E Int J Parasitol; 2002 Dec; 32(13):1669-76. PubMed ID: 12435452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]